Skip to main content
Frontiers in Endocrinology logoLink to Frontiers in Endocrinology
. 2020 Oct 9;11:596223. doi: 10.3389/fendo.2020.596223

Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAFV600E: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment

Mark Duquette 1, Peter M Sadow 2, Jack Lawler 3, Carmelo Nucera 1,*
PMCID: PMC7584128  PMID: 33162943

In the original article, there was a mistake in Figure 1 as published. The authors note a mislabeling of the cell lines name which appeared in Fig.1 left upper panel and have corrected it, andthe loading control was replaced. This correction is not of scientific nature and does not change results and conclusions of the article. The corrected Figure 1 appears below.

The authors apologize and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Figure 1.

Figure 1

TSP-1, ITGα6, ITGα3, ITGβ1, and pFAK protein levels by western blot in human anaplastic thyroid cancer (ATC) cell lines with sh-GFP (green fluorescent protein, control) or knock-down of TSP-1 (#7 and #8) harboring heterozygous BRAFWT/V600E (SW1736 cells) or homozygous BRAFV600E (8505c cells).


Articles from Frontiers in Endocrinology are provided here courtesy of Frontiers Media SA

RESOURCES